Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphoma
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
17723
Cancer Research UK - United Kingdom
PubMed
30666658
DOI
10.1002/path.5237
Knihovny.cz E-zdroje
- Klíčová slova
- CD40, DLBCL, EBV, LMP1, S1P, S1PR2,
- MeSH
- 1-fosfatidylinositol-3-kinasa metabolismus MeSH
- antigeny CD40 genetika metabolismus MeSH
- databáze genetické MeSH
- difúzní velkobuněčný B-lymfom genetika metabolismus mortalita virologie MeSH
- infekce virem Epsteina-Barrové mortalita virologie MeSH
- interakce hostitele a patogenu MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- prognóza MeSH
- proteiny virové matrix genetika metabolismus MeSH
- protoonkogenní proteiny c-akt metabolismus MeSH
- receptory sfingosin-1-fosfátu genetika metabolismus MeSH
- regulace genové exprese u nádorů MeSH
- signální transdukce MeSH
- virová transformace buněk MeSH
- virus Epsteinův-Barrové genetika metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 1-fosfatidylinositol-3-kinasa MeSH
- antigeny CD40 MeSH
- EBV-associated membrane antigen, Epstein-Barr virus MeSH Prohlížeč
- proteiny virové matrix MeSH
- protoonkogenní proteiny c-akt MeSH
- receptory sfingosin-1-fosfátu MeSH
- S1PR2 protein, human MeSH Prohlížeč
The Epstein-Barr virus (EBV) is found almost exclusively in the activated B-cell (ABC) subtype of diffuse large B-cell lymphoma (DLBCL), yet its contribution to this tumour remains poorly understood. We have focused on the EBV-encoded latent membrane protein-1 (LMP1), a constitutively activated CD40 homologue expressed in almost all EBV-positive DLBCLs and which can disrupt germinal centre (GC) formation and drive lymphomagenesis in mice. Comparison of the transcriptional changes that follow LMP1 expression with those that follow transient CD40 signalling in human GC B cells enabled us to define pathogenic targets of LMP1 aberrantly expressed in ABC-DLBCL. These included the down-regulation of S1PR2, a sphingosine-1-phosphate (S1P) receptor that is transcriptionally down-regulated in ABC-DLBCL, and when genetically ablated leads to DLBCL in mice. Consistent with this, we found that LMP1-expressing primary ABC-DLBCLs were significantly more likely to lack S1PR2 expression than were LMP1-negative tumours. Furthermore, we showed that the down-regulation of S1PR2 by LMP1 drives a signalling loop leading to constitutive activation of the phosphatidylinositol-3-kinase (PI3-K) pathway. Finally, core LMP1-PI3-K targets were enriched for lymphoma-related transcription factors and genes associated with shorter overall survival in patients with ABC-DLBCL. Our data identify a novel function for LMP1 in aggressive DLBCL. Copyright © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Department of Histopathology Heartlands Hospital Birmingham UK
Department of Pathology Universiti Putra Malaysia Seri Kembangan Malaysia
Institute of Cancer and Genomic Sciences University of Birmingham Birmingham UK
Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK
Leeds Institute of Cancer and Pathology University of Leeds Leeds UK
Research Unit Cellular Signal Integration Helmholtz Zentrum München Neuherberg Germany
Sheffield Institute of Translational Neuroscience University of Sheffield Sheffield UK
Citace poskytuje Crossref.org